Patricia Minaya Flores1, Julie Berbis1, Olivier Chinot1, Pascal Auquier1. 1. School of Medicine , Aix-Marseilles University, Marseilles, France (P.M.F., J.B., P.A.); EA3279, Self-perceived Health Assessment Research Unit , Marseilles , France (P.M.F., J.B., P.A.); Timone University Hospital, Department of Neurooncology , Marseilles , France (O.C.).
Abstract
BACKGROUND: The aim of the study was to analyze the impact of gliomas in caregivers' quality of life (QoL) and to compare this specific population to other oncology caregivers and the normative population in order to find differences and understand which aspects of QoL are more impacted. METHODS: The sample was composed of caregivers of patients with gliomas from the Neuro-Oncology Department of Timone University Hospital of Marseilles, France. Control caregivers were selected from different oncology departments and were matched with caregivers of patients with brain cancer on age, sex, and relationship with the patients. We used the specific CareGiver Oncology Quality of Life questionnaire (CarGOQoL) to assess the impact of cancer and its treatment on caregivers' QoL. Caregivers also completed the Short Form 36 (SF36) for comparison with the French normative sample. RESULTS: The study sample included 50 caregivers of patients with gliomas, aged 30-77 years, 28% of whom were men. When comparing specific CarGOQoL scores with those of the control caregivers, brain cancer caregivers had significantly lower scores for the burden and leisure time dimensions, with an effect size of 0.4. No significant differences between cases and controls were observed with SF36. CONCLUSION: Caregivers of patients with gliomas showed increased burden scores and lower scores for the leisure time dimension. This could be explained by their unique care situation, in which patients become more limited physically and cognitively.
BACKGROUND: The aim of the study was to analyze the impact of gliomas in caregivers' quality of life (QoL) and to compare this specific population to other oncology caregivers and the normative population in order to find differences and understand which aspects of QoL are more impacted. METHODS: The sample was composed of caregivers of patients with gliomas from the Neuro-Oncology Department of Timone University Hospital of Marseilles, France. Control caregivers were selected from different oncology departments and were matched with caregivers of patients with brain cancer on age, sex, and relationship with the patients. We used the specific CareGiver Oncology Quality of Life questionnaire (CarGOQoL) to assess the impact of cancer and its treatment on caregivers' QoL. Caregivers also completed the Short Form 36 (SF36) for comparison with the French normative sample. RESULTS: The study sample included 50 caregivers of patients with gliomas, aged 30-77 years, 28% of whom were men. When comparing specific CarGOQoL scores with those of the control caregivers, brain cancer caregivers had significantly lower scores for the burden and leisure time dimensions, with an effect size of 0.4. No significant differences between cases and controls were observed with SF36. CONCLUSION: Caregivers of patients with gliomas showed increased burden scores and lower scores for the leisure time dimension. This could be explained by their unique care situation, in which patients become more limited physically and cognitively.
Entities:
Keywords:
brain cancer; burden; caregivers; gliomas; quality of life
Authors: Stephen T Keir; Ann Bebe Guill; Karen E Carter; Lindsay C Boole; Lazaro Gonzales; Henry S Friedman Journal: Support Care Cancer Date: 2006-06-15 Impact factor: 3.603
Authors: Florien W Boele; Jan J Heimans; Neil K Aaronson; Martin J B Taphoorn; Tjeerd J Postma; Jaap C Reijneveld; Martin Klein Journal: J Neurooncol Date: 2013-07-04 Impact factor: 4.130
Authors: Jong Im Song; Dong Wook Shin; Jin Young Choi; Jina Kang; Young Ji Baik; Hana Mo; Myung Hee Park; Sung Eun Choi; Jeong Ho Kwak; Eun Jin Kim Journal: Support Care Cancer Date: 2011-04-10 Impact factor: 3.603
Authors: Paula Sherwood; Barbara Given; Charles Given; Rachel Schiffman; Daniel Murman; Mary Lovely Journal: Nurs Inq Date: 2004-03 Impact factor: 2.393
Authors: M Mauer; R Stupp; M J B Taphoorn; C Coens; D Osoba; C Marosi; R Wong; O de Witte; J G Cairncross; F Efficace; R O Mirimanoff; P Forsyth; M J van den Bent; M Weller; A Bottomley Journal: Br J Cancer Date: 2007-07-03 Impact factor: 7.640
Authors: K Baumstarck; T Leroy; Z Hamidou; E Tabouret; P Farina; M Barrié; C Campello; G Petrirena; O Chinot; P Auquier Journal: J Neurooncol Date: 2016-06-14 Impact factor: 4.130
Authors: Sarah C Kaveney; Karine Baumstarck; Patricia Minaya-Flores; Tarrah Shannon; Philip Symes; Anderson Loundou; Pascal Auquier Journal: Health Qual Life Outcomes Date: 2016-05-28 Impact factor: 3.186
Authors: Emma Nicklin; Lucy Pointon; Adam Glaser; Naseem Sarwar; Michelle Kwok-Williams; Miguel Debono; Galina Velikova; Florien W Boele Journal: Support Care Cancer Date: 2021-04-16 Impact factor: 3.603